FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Sai Silks (Kalamandir) IPO and Valiant Laboratories IPO.
Sai Silks (Kalamandir) IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Valiant Laboratories IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Sai Silks (Kalamandir) IPO | Valiant Laboratories IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Motilal Oswal Investment Advisors Limited Hdfc Bank Limited Nuvama Wealth Management Limited |
Unistone Capital Pvt Ltd |
Registrar | Bigshare Services Pvt Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Sai Silks (Kalamandir) IPO is up to ₹1,201.00 Cr whereas the issue size of the Valiant Laboratories IPO is up to ₹152.46 Cr. The final issue price of Sai Silks (Kalamandir) IPO is ₹222.00 per share and of Valiant Laboratories IPO is ₹140.00 per share.
Sai Silks (Kalamandir) IPO | Valiant Laboratories IPO | |
---|---|---|
Face Value | ₹2 per share | ₹10 per share |
Issue Price (Lower) | ₹210.00 per share | ₹133.00 per share |
Issue Price (Upper) | ₹222.00 per share | ₹140.00 per share |
Issue Price (Final) | ₹222.00 per share | ₹140.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 67 shares | 105 shares |
Fresh Issue Size | 2,70,27,027 shares | 1,08,90,000 shares |
Fresh Issue Size (Amount) | up to ₹600.00 Cr | up to ₹152.46 Cr |
OFS Issue Size | 2,70,72,000 shares | |
OFS Issue Size (Amount) | up to ₹601.00 Cr | |
Issue Size Total | 5,40,99,027 shares | 1,08,90,000 shares |
Issue Size Total (Amount) | up to ₹1,201.00 Cr | up to ₹152.46 Cr |
Sai Silks (Kalamandir) IPO opens on Sep 20, 2023, while Valiant Laboratories IPO opens on Sep 27, 2023. The closing date of Sai Silks (Kalamandir) IPO and Valiant Laboratories IPO is Sep 22, 2023, and Oct 03, 2023, respectively.
Sai Silks (Kalamandir) IPO | Valiant Laboratories IPO | |
---|---|---|
Anchor Bid Date | Sep 18, 2023 | Sep 26, 2023 |
Issue Open | Sep 20, 2023 | Sep 27, 2023 |
Issue Close | Sep 22, 2023 | Oct 03, 2023 |
Basis Of Allotment (Tentative) | Sep 27, 2023 | Oct 05, 2023 |
Initiation of Refunds (Tentative) | Sep 29, 2023 | Oct 06, 2023 |
Credit of Share (Tentative) | Oct 03, 2023 | Oct 06, 2023 |
Listing date (Tentative) | Sep 27, 2023 | Oct 06, 2023 |
Anchor Lockin End date 1 | Oct 27, 2023 | Nov 04, 2023 |
Anchor Lockin End date 2 | Dec 26, 2023 | Jan 03, 2024 |
Sai Silks (Kalamandir) IPO P/E ratio is 27.37, as compared to Valiant Laboratories IPO P/E ratio of 15.71.
Sai Silks (Kalamandir) IPO | Valiant Laboratories IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Sai Silks (Kalamandir) Limited Financial Information (Restated)Sai Silks (Kalamandir) Limited's revenue increased by 19.94% and profit after tax (PAT) rose by 69.17% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Amount in ₹ Crore |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 95.23% | 100.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 60.80% | 74.94% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 27.37 | 15.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹3404.73 Cr. | ₹608.30 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 27.96%% | 33.73%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 23.55%% | 22.76%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.87 | 0.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹8.11 | ₹8.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 24.56%% | 28.86%% |
In the Sai Silks (Kalamandir) IPO retail investors (RII) are offered 1,89,34,659 shares while in Valiant Laboratories IPO retail investors are offered 1,89,34,659 shares. Qualified institutional buyers (QIB) are offered 1,08,19,807 shares in Sai Silks (Kalamandir) IPO and 21,78,030 shares in Valiant Laboratories IPO.
Sai Silks (Kalamandir) IPO | Valiant Laboratories IPO | |
---|---|---|
Anchor Investor Reserveration | 1,62,29,707 shares | 32,66,970 shares |
Market Maker Reserveration | ||
QIB | 1,08,19,807 shares | 21,78,030 shares |
NII | 81,14,854 shares | 16,33,500 shares |
RII | 1,89,34,659 shares | 38,11,500 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 3,78,69,320 shares | 76,23,030 shares |
Sai Silks (Kalamandir) IPO subscribed 4.47x in total, whereas Valiant Laboratories IPO subscribed 29.76x.
Sai Silks (Kalamandir) IPO | Valiant Laboratories IPO | |
---|---|---|
QIB (times) | 12.17x | 20.83x |
NII (times) | 2.54x | 73.64x |
Big NII (times) | 3.03x | 78.64x |
Small NII (times) | 1.57x | 63.64x |
RII (times) | 0.91x | 16.06x |
Employee (times) | ||
Other (times) | ||
Total (times) | 4.47x | 29.76x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|